Literature DB >> 3396817

Psychosocial factors in the irritable bowel syndrome. A multivariate study of patients and nonpatients with irritable bowel syndrome.

D A Drossman1, D C McKee, R S Sandler, C M Mitchell, E M Cramer, B C Lowman, A L Burger.   

Abstract

In this multivariate analysis of the irritable bowel syndrome (IBS) we describe the symptomatic and psychologic features of the condition and their possible contributions to health care seeking. We studied 72 IBS patients, 82 persons with IBS who had not sought medical treatment, and 84 normal subjects. All subjects received complete medical evaluation, diary card assessment of abdominal pain and stool habit, and standard psychologic tests of pain, personality, mood, stressful life events, illness behavior, and social support. Pain and diarrhea were the most important symptoms associated with patient status. When controlling for these symptoms we found that (a) IBS patients have a higher proportion of abnormal personality patterns, greater illness behaviors, and lower positive stressful life event scores than IBS nonpatients (p less than 0.001) and normals (p less than 0.001); (b) IBS nonpatients, although psychologically intermediate between patients and normals, are not different from normals (p less than 0.21); and (c) IBS nonpatients have higher coping capabilities, experience illness as less disruptive to life, and tend to exhibit less psychologic denial than patients. These factors may contribute to "wellness behaviors" among people with chronic bowel symptoms. We conclude that the psychologic factors previously attributed to the IBS are associated with patient status rather than to the disorder per se. These factors may interact with physiologic disturbances in the bowel to determine how the illness is experienced and acted upon.

Entities:  

Mesh:

Year:  1988        PMID: 3396817     DOI: 10.1016/s0016-5085(88)80017-9

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  150 in total

Review 1.  The functional gastrointestinal disorders and the Rome II process.

Authors:  D A Drossman
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

2.  British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome.

Authors:  J Jones; J Boorman; P Cann; A Forbes; J Gomborone; K Heaton; P Hungin; D Kumar; G Libby; R Spiller; N Read; D Silk; P Whorwell
Journal:  Gut       Date:  2000-11       Impact factor: 23.059

Review 3.  The role of psychosocial factors in gastrointestinal disorders.

Authors:  I Wilhelmsen
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

Review 4.  Non-pharmacological treatments in the irritable bowel syndrome.

Authors:  A Leahy; O Epstein
Journal:  World J Gastroenterol       Date:  2001-06       Impact factor: 5.742

Review 5.  Natural history of dyspepsia.

Authors:  Lars Agréus
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

6.  Irritable bowel syndrome: patterns of ambulatory health care and resource use in the United States, 1993-1997.

Authors:  Jennifer Hollowell; Annika Lundgren; Saga Johansson
Journal:  Dig Dis Sci       Date:  2002-05       Impact factor: 3.199

7.  Colonic motor function in humans is not affected by gender.

Authors:  E E Soffer; K Kongara; J P Achkar; J Gannon
Journal:  Dig Dis Sci       Date:  2000-07       Impact factor: 3.199

Review 8.  The role of primary care physicians in managing depression.

Authors:  D S Brody; D B Larson
Journal:  J Gen Intern Med       Date:  1992 Mar-Apr       Impact factor: 5.128

Review 9.  Psychiatric comorbidity in fibromyalgia.

Authors:  Laurence A Bradley
Journal:  Curr Pain Headache Rep       Date:  2005-04

10.  Homozygous 825T allele of the GNB3 protein influences the susceptibility of Japanese to dyspepsia.

Authors:  Tomomitsu Tahara; Tomiyasu Arisawa; Tomoyuki Shibata; Fangyu Wang; Masakatsu Nakamura; Mikijyu Sakata; Ichiro Hirata; Hiroshi Nakano
Journal:  Dig Dis Sci       Date:  2007-08-24       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.